Prehospital-initiated thrombolysis

Annals of Pharmacotherapy

Volumn 31, Issue 11, 1997, Pages 1339-1346

  Spinler, Sarah A ^a,c   Mikhail, Peter A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Philadelphia Coll Pharm and Sci   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Acute myocardial infarction; Alteplase; Anisoylated streptokinase plasminogen activator complex; Streptokinase; Thrombolytic agents; Urokinase

Indexed keywords

ALTEPLASE; PLASMINOGEN ACTIVATOR; STREPTOKINASE; UROKINASE;

BLOOD CLOT LYSIS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; EPIDEMIOLOGICAL DATA; HEART INFARCTION; HEART VENTRICLE FUNCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT PLANNING;

EID: 0030670371     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703101112     Document Type: Review

References (30)

1. American Heart Association 1997 heart and stroke statistical update. Coronary heart disease [cited 1997 March 14]. Available from: http:// www.amhrt.org/1997/stats/CorHtDis.html.
2. Holmes DR Jr, Califf RM, Topol EJ. Lessons we have learned from the GUSTO Trial. J Am Coll Cardiol 1995;25(suppl):10S-7S.
3. Tavazzi L, Volpi A. Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) trials. Circulation 1997;95:1341-5.
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994;343:311-22.
5. Newby LK, Rutsch WR, Califf RM, Simoons ML, Aylward PE, Armstrong PW, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-I Investigators. J Am Coll Cardiol 1996;27:1646-55.
6. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
7. Simes RJ, Topol EJ, Holmes DR Jr, White HD, Rutsch WR, Vahanian A, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. Circulation 1995;91: 1923-8.
8. Califf RM, Newby LK. How much do we gain by reducing time to reperfusion therapy? Am J Cardiol 1996;78(suppl 12A):8-15.
9. Weaver DW. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol 1995;25(suppl):3S-9S.
10. McNeill AJ, Cunningham SR, Flannery DJ, Dalzell GWN, Wilson CM, Campbell NPS, et al. A double-blind placebo-controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction. Br Heart J 1989;61:316-21.
11. Castaigne AD, Herve C, Duval-Moulin A, Martine G, Dubois-Rande J-L, Boesch C, et al. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol 1989;64:30A-3A.
12. Barbash GI, Roth A, Hanoch H, Hilton M, Michaela M, Shemuel R, et al. Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol 1990;66:261-6.
13. Schofer J, Buttner J, Geng G, Gutschmidt K, Herden HN, Mathey DG, et al. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1990;66:1428-33.
14. McAleer B, Ruane B, Burke E. Prehospital thrombolysis in a rural community: short and long term survival. Cardiovasc Drugs Ther 1992;6: 369-72.
15. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region Early Anistreplase Trial. BMJ 1992;305:548-53.
16. Rawles J. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1994;23:1-5.
17. Weaver WD, Cerueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial (MITI). JAMA 1993;270:1211-6.
18. Brouwer MA, Martin JS, Maynard C, Wirkus M, Litwin P, Freek W, et al. Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). Am J Cardiol 1996;78:497-502.
19. The European Myocardial Infarction Project (EMIP) Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329:383-9.
20. Weaver WD, Einsenberg MS, Martin JS, Litwin PE, Shaeffer SM, Ho MT, et al. Myocardial Infarction Triage and Intervention Project -phase 1: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol 1990;15:925-31.
21. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1996;28:1328-428.
22. Fath-Ordoubadi F, Al-Mohammad A, Huehns TY, Beatt KJ. Meta-analysis of randomized trials of prehospital versus hospital thrombolysis (abstract). Circulation 1994;90(suppl 4 pt 2):I-325.
23. Pashos CL, Norman S-LT, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol 1994;23:1023-30.
24. Ellerbeck EF, Jencks SF, Radford MJ, Kresowik TF, Craig AS, Gold JA, et al. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA 1995;273:1509-14.
25. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolytics for acute myocardial infarction. Lancet 1996;347:1203-7.
26. Krumholz HM, Pasternak RC, Weinstein MC, Friesinger GC, Ridker PM, Tosteson ANA, et al. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected myocardial infarction. N Engl J Med 1992;327:7-13.
27. LATE Study Group. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66.
28. Dracup K, Alonzo AA, Atkins JM, Bennett NM, Braslow A, Clark LT, et al. The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Ann Intern Med 1997;126:645-51.
29. Maynard C, Weaver DW. Streamlining the triage system for acute myocardial infarction. Cardiol Clin 1995;13:311-20.
30. Canto JG, Rogers WJ, Bowlby LJ, French WJ, Pearce DJ, Weaver WB. The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? J Am Coll Cardiol 1997;29:498-505.